About the Journal
Aims and scope of journal
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
Why publish with Translational Psychiatry?
We are the highest-ranked open access journal in Psychiatry, with the aim of bridging the gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients.
Open access publication ensures that your article can be easily discovered, accessed, used, and shared, maximizing your impact and acting as a springboard for further discovery.
We provide a clear and supportive publication process, and ensure high visibility for your publication through our nature.com platform.
Our highly-respected editorial team leads a rigorous and rapid peer review process.
The 2019 journal metrics* for Translational Psychiatry are as follows:
- 2-year impact factor: 5.28
- 5-year impact factor: 5.904
- Immediacy index: 0.745
- Eigenfactor ® score: 0.02486
- Article influence score: 1.822
- Rank: 18/146 in Psychiatry
*2019 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
- 5406 Altmetric mentions
- 1,417,295 Downloads
40 days from submission to 1st decision
148 days from submission to acceptance
17 days from acceptance to publication
ISI Web of Science
ISSN and E-ISSN
The ISSN (online) number for Translational Psychiatry is 2158-3188.